Ocugen IncNASDAQ:OCGN
- LAST PRICE1.0800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.2100/ 6
- Ask / Lots1.2300/ 1
- Open / Previous Close--- / 1.0800
- Day Range---
- 52 Week Range
- Volume129,266
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCGN |
|---|---|---|
| 09:32 ET | 229822 | 1.0801 |
| 09:33 ET | 79698 | 1.065 |
| 09:35 ET | 96771 | 1.06 |
| 09:37 ET | 87850 | 1.06 |
| 09:39 ET | 42664 | 1.075 |
| 09:42 ET | 141207 | 1.075 |
| 09:44 ET | 26137 | 1.0782 |
| 09:46 ET | 75566 | 1.0826 |
| 09:48 ET | 7282 | 1.09 |
| 09:50 ET | 51443 | 1.0858 |
| 09:51 ET | 40368 | 1.0897 |
| 09:53 ET | 35779 | 1.085 |
| 09:55 ET | 28177 | 1.085 |
| 09:57 ET | 18825 | 1.09 |
| 10:00 ET | 17716 | 1.0801 |
| 10:02 ET | 64740 | 1.075 |
| 10:04 ET | 13378 | 1.07 |
| 10:06 ET | 5013 | 1.0718 |
| 10:08 ET | 51697 | 1.06 |
| 10:09 ET | 17963 | 1.0638 |
| 10:11 ET | 40140 | 1.065 |
| 10:13 ET | 6631 | 1.065 |
| 10:15 ET | 10698 | 1.07 |
| 10:18 ET | 38316 | 1.06 |
| 10:20 ET | 14853 | 1.065 |
| 10:22 ET | 19315 | 1.06 |
| 10:24 ET | 16249 | 1.06 |
| 10:26 ET | 123580 | 1.055 |
| 10:27 ET | 6815 | 1.055 |
| 10:29 ET | 1776 | 1.05 |
| 10:31 ET | 173172 | 1.065 |
| 10:33 ET | 13557 | 1.074 |
| 10:36 ET | 8994 | 1.078803 |
| 10:38 ET | 5846 | 1.07 |
| 10:40 ET | 11806 | 1.085 |
| 10:42 ET | 5487 | 1.0886 |
| 10:44 ET | 8315 | 1.0899 |
| 10:45 ET | 34358 | 1.075 |
| 10:47 ET | 13181 | 1.08 |
| 10:49 ET | 44636 | 1.0887 |
| 10:51 ET | 16546 | 1.0834 |
| 10:54 ET | 6850 | 1.0845 |
| 10:56 ET | 23161 | 1.09 |
| 10:58 ET | 12726 | 1.09 |
| 11:00 ET | 11390 | 1.0845 |
| 11:02 ET | 9498 | 1.09 |
| 11:03 ET | 7988 | 1.083 |
| 11:05 ET | 111603 | 1.08 |
| 11:07 ET | 58649 | 1.08 |
| 11:09 ET | 61960 | 1.09 |
| 11:12 ET | 14058 | 1.09 |
| 11:14 ET | 25628 | 1.09 |
| 11:16 ET | 4702 | 1.0867 |
| 11:18 ET | 23850 | 1.0885 |
| 11:20 ET | 3077 | 1.085 |
| 11:21 ET | 51638 | 1.0746 |
| 11:23 ET | 11869 | 1.0722 |
| 11:25 ET | 1286 | 1.075 |
| 11:27 ET | 540 | 1.075 |
| 11:30 ET | 6610 | 1.0703 |
| 11:32 ET | 16697 | 1.0796 |
| 11:34 ET | 1612 | 1.076 |
| 11:36 ET | 13421 | 1.07 |
| 11:38 ET | 3081 | 1.0704 |
| 11:39 ET | 22589 | 1.0797 |
| 11:41 ET | 1114 | 1.08 |
| 11:43 ET | 3831 | 1.08 |
| 11:45 ET | 620 | 1.075 |
| 11:48 ET | 1660 | 1.0799 |
| 11:50 ET | 4500 | 1.08 |
| 11:52 ET | 14516 | 1.0763 |
| 11:54 ET | 4727 | 1.08 |
| 11:56 ET | 2048 | 1.08 |
| 11:57 ET | 6128 | 1.08 |
| 11:59 ET | 3616 | 1.07 |
| 12:01 ET | 3157 | 1.075 |
| 12:03 ET | 128692 | 1.08 |
| 12:06 ET | 3502 | 1.0804 |
| 12:08 ET | 42923 | 1.08 |
| 12:10 ET | 5264 | 1.08 |
| 12:12 ET | 1750 | 1.085 |
| 12:14 ET | 4190 | 1.08 |
| 12:15 ET | 10143 | 1.09 |
| 12:17 ET | 12015 | 1.085 |
| 12:19 ET | 6860 | 1.08 |
| 12:21 ET | 4434 | 1.09 |
| 12:24 ET | 9437 | 1.0863 |
| 12:26 ET | 6565 | 1.08 |
| 12:28 ET | 800 | 1.085 |
| 12:30 ET | 10965 | 1.0844 |
| 12:32 ET | 2874 | 1.09 |
| 12:33 ET | 3040 | 1.08 |
| 12:35 ET | 12846 | 1.08 |
| 12:37 ET | 5351 | 1.09 |
| 12:39 ET | 5450 | 1.08937 |
| 12:42 ET | 560 | 1.08 |
| 12:44 ET | 20832 | 1.085 |
| 12:46 ET | 8210 | 1.09 |
| 12:48 ET | 31815 | 1.075 |
| 12:50 ET | 5236 | 1.07 |
| 12:51 ET | 4847 | 1.07 |
| 12:53 ET | 5140 | 1.075 |
| 12:55 ET | 634 | 1.07 |
| 12:57 ET | 24226 | 1.0762 |
| 01:00 ET | 8341 | 1.07 |
| 01:02 ET | 1983 | 1.0754 |
| 01:04 ET | 1031 | 1.075 |
| 01:06 ET | 2738 | 1.0749 |
| 01:08 ET | 7469 | 1.07 |
| 01:09 ET | 1207 | 1.075 |
| 01:11 ET | 3231 | 1.075 |
| 01:13 ET | 3736 | 1.075 |
| 01:15 ET | 500 | 1.0701 |
| 01:18 ET | 2874 | 1.07 |
| 01:20 ET | 3714 | 1.075 |
| 01:22 ET | 1656 | 1.08 |
| 01:24 ET | 207 | 1.07 |
| 01:26 ET | 5373 | 1.075 |
| 01:27 ET | 1277 | 1.08 |
| 01:31 ET | 1799 | 1.07 |
| 01:33 ET | 2944 | 1.0796 |
| 01:36 ET | 16046 | 1.08 |
| 01:38 ET | 18659 | 1.075 |
| 01:40 ET | 3240 | 1.075 |
| 01:42 ET | 7541 | 1.0747 |
| 01:44 ET | 523 | 1.0721 |
| 01:45 ET | 139634 | 1.06 |
| 01:47 ET | 29618 | 1.065 |
| 01:49 ET | 5605 | 1.06 |
| 01:51 ET | 14378 | 1.06 |
| 01:54 ET | 146527 | 1.045 |
| 01:56 ET | 5800 | 1.05 |
| 01:58 ET | 23621 | 1.05 |
| 02:00 ET | 26114 | 1.05 |
| 02:02 ET | 2555 | 1.05 |
| 02:03 ET | 3714 | 1.05 |
| 02:05 ET | 7450 | 1.05 |
| 02:07 ET | 16764 | 1.06 |
| 02:09 ET | 5907 | 1.05 |
| 02:12 ET | 23267 | 1.0591 |
| 02:14 ET | 14064 | 1.055 |
| 02:16 ET | 1800 | 1.06 |
| 02:18 ET | 700 | 1.06 |
| 02:20 ET | 42662 | 1.065 |
| 02:21 ET | 1085 | 1.065 |
| 02:23 ET | 1475 | 1.06 |
| 02:25 ET | 13640 | 1.0699 |
| 02:27 ET | 34600 | 1.0746 |
| 02:30 ET | 25353 | 1.075 |
| 02:32 ET | 4360 | 1.07 |
| 02:34 ET | 2341 | 1.075 |
| 02:36 ET | 3085 | 1.08 |
| 02:38 ET | 18782 | 1.08 |
| 02:39 ET | 15698 | 1.075 |
| 02:41 ET | 1599 | 1.0775 |
| 02:43 ET | 3958 | 1.075 |
| 02:45 ET | 73226 | 1.08 |
| 02:48 ET | 10364 | 1.08 |
| 02:50 ET | 48668 | 1.09 |
| 02:52 ET | 38121 | 1.095 |
| 02:54 ET | 23647 | 1.09 |
| 02:56 ET | 9241 | 1.095 |
| 02:57 ET | 36159 | 1.09 |
| 02:59 ET | 17654 | 1.085 |
| 03:01 ET | 17256 | 1.085 |
| 03:03 ET | 5955 | 1.09 |
| 03:06 ET | 5961 | 1.085 |
| 03:08 ET | 6600 | 1.085 |
| 03:10 ET | 10695 | 1.09 |
| 03:12 ET | 15123 | 1.08 |
| 03:14 ET | 18492 | 1.089318 |
| 03:15 ET | 26323 | 1.0951 |
| 03:17 ET | 7019 | 1.0928 |
| 03:19 ET | 17123 | 1.095 |
| 03:21 ET | 34403 | 1.095 |
| 03:24 ET | 3050 | 1.095 |
| 03:26 ET | 24315 | 1.085 |
| 03:28 ET | 28725 | 1.085 |
| 03:30 ET | 20934 | 1.085 |
| 03:32 ET | 20074 | 1.085 |
| 03:33 ET | 2766 | 1.085 |
| 03:35 ET | 15493 | 1.0866 |
| 03:37 ET | 14551 | 1.085 |
| 03:39 ET | 10530 | 1.085 |
| 03:42 ET | 4844 | 1.0859 |
| 03:44 ET | 29704 | 1.08 |
| 03:46 ET | 14657 | 1.085 |
| 03:48 ET | 95778 | 1.085 |
| 03:50 ET | 3520 | 1.0849 |
| 03:51 ET | 43835 | 1.09 |
| 03:53 ET | 20881 | 1.09 |
| 03:55 ET | 8194 | 1.085 |
| 03:57 ET | 31594 | 1.09 |
| 04:00 ET | 376147 | 1.08 |
Yesterday
Ocugen Secures $30 Million in Debt Funding, from 23 hours ago by Dow Jones
23 hours ago by Dow Jones
Nov 1, 2024
Attention Ocugen, Inc. (OCGN) Shareholders: Grabar Law Office Investigates Claims on Your Behalf, from 8:14AM ET on Friday Nov 01, 2024 by Dow Jones
8:14AM ET on Friday Nov 01, 2024 by Dow Jones
Oct 28, 2024
Oct 23, 2024
DJ Ocugen Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 7:30AM ET on Wednesday Oct 23, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 22, 2024
Data and Safety Monitoring Board Approves Initiation of Phase 2 of OCU410ST GARDian Clinical Trial for Stargardt Disease, from 7:02AM ET on Tuesday Oct 22, 2024 by Dow Jones
7:02AM ET on Tuesday Oct 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocugen Inc | 310.9M | -6.0x | --- |
Lyell Immunopharma Inc | 313.0M | -1.5x | --- |
Northwest Biotherapeutics Inc | 325.8M | -4.1x | --- |
Aldeyra Therapeutics Inc | 317.3M | -8.4x | --- |
Rezolute Inc | 319.9M | -4.3x | --- |
Abeona Therapeutics Inc | 276.3M | -3.0x | --- |
Company Information
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
Contact Information
- Headquarters
- 11 GREAT VALLEY PARKWAYMALVERN, PA, United States 19355
- Phone
- 484-328-4701
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer, Interim Principal Financial Officer
- Shankar Musunuri
- Controller
- Michael Breininger
- Chief Scientific Officer, Executive Officer
- Arun Upadhyay
- Chief Medical Officer
- Huma Qamar
- Independent Director
- Kirsten Castillo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $310.9M |
|---|---|
Revenue (TTM) | $8.2M |
Shares Outstanding | 287.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.88 |
EPS | $-0.18 |
Book Value | $0.16 |
P/E Ratio | -6.0x |
Price/Sales (TTM) | 38.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -631.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
